Back

Hyperkalemia in chronic kidney disease: incidence, prevalence and impact on RAAS inhibitors treatment in primary care in Scotland.

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Renal failure and cardiovascular disease Renal Failure and Cardiovascular Disease ESC Premium Access ESC Congress 2018

About the speaker

Photo
Mr Alex Simpson

Evidera Inc, London (United Kingdom of Great Britain & Northern Ireland)

8 More presentations in this session

Presentation thumbnail
Cardiac iodine-123 metaiodobenzylguanidine imaging predicts frequent hypotension during hemodialysis in patients with end-stage renal disease.
Doctor M. Koyama (Sapporo, JP)
Abstract
Presentation thumbnail
Performance of the Cockcroft-Gault, MDRD and CKD-EPI Formulae in Atrial Fibrillation patients.The FANTASIIA Registry.
Doctor M. Esteve Pastor (Murcia, ES)
Abstract
Presentation thumbnail
Different definitions of contrast-induced renal failure and its course after invasive treatment of acute myocardial infarction in patients without chronic kidney disease
Associate Professor J. Kowalczyk (Zabrze, PL)
Abstract
Presentation thumbnail
Interest and potential risk of increasing concentration potassium in the dialysis bath in patients on chronic hemodialysis
Doctor F. Krzesinski (Liege, BE)
Abstract Slides
Presentation thumbnail
Left atrium changes in patients with maintenance hemodialysis: assessment via three-dimensional speckle tracking echocardiography
Doctor M. Sun (Shanghai, CN)
Abstract

Access the full session

Session thumbnail
Poster Session 4 - Renal failure and cardiovascular disease

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources